Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol + Hydrocortisone in Pediatric Facial Psoriasis
NCT01007591Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcipotriol + hydrocortisone in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Oct 2009; status: completed.
02
Drugs
calcipotriol + hydrocortisone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01007591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007591.